NCT00004286View on ClinicalTrials.gov

Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

February 29, 1996

Study Completion Date

November 30, 1999

Conditions

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Interventions

DRUG

immune globulin

All Listed Sponsors

collaborator

University of Vermont

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004286 - Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy | Biotech Hunter | Biotech Hunter